REVANCE THERAPEUTICS INC

CUSIP: 761330109 Class: Common Stock

Brevan Howard Capital Management LP's Holding History (CIK: 0001512857)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 522,716 Value ($000) $2,713 Avg Close — Range —
Q2 2024
Shares 39,268 Value ($000) $101 Avg Close — Range —
Q4 2023
Shares 27,111 Value ($000) $238 Avg Close — Range —